Streetbeat News

CRLBF

Cresco Labs Inc.

http://www.crescolabs.com/

CEO

Charles Bachtell

Employees

3,500

Industry

Medicinal and Botanical Manufacturing

Open

0.89

Mkt cap

397M

Volume

137K

High

0.90

P/E Ratio

-4.94

52-wk high

2.65

Low

0.88

Div yield

N/A

52-wk low

0.78

The marijuana industry is poised for significant developments in 2025, with potential legalization in remaining US states and the introduction of cannabis lounges. These changes could boost the market and drive reform.

Portfolio Pulse from

January 06, 2025 | 2:30 pm

The US cannabis industry is experiencing significant growth, with the market expected to grow from $33 billion in 2024 to over $60 billion by 2030. This growth is driven by state-level legalization, medical program development, and potential federal policy reforms like the SAFE Banking Act, which could enhance banking access for cannabis companies.

Portfolio Pulse from

December 31, 2024 | 3:15 pm

The US cannabis industry is poised for growth with a projected market value over $40 billion by 2025. Companies like Trulieve, Cresco Labs, and Verano Holdings are key players. Federal legalization discussions could further boost the sector.

Portfolio Pulse from

December 24, 2024 | 3:15 pm

The US cannabis sector has seen a recent pullback due to market volatility and regulatory concerns, creating potential buying opportunities for undervalued stocks. Despite short-term challenges, the long-term outlook remains positive, with the market expected to exceed $41 billion by 2025.

Portfolio Pulse from

December 12, 2024 | 3:15 pm

The marijuana industry is poised for potential growth in 2025, with expectations of reduced volatility and increased momentum in marijuana stocks. Comprehensive reform and relaxed policies could significantly advance the industry.

Portfolio Pulse from

December 04, 2024 | 2:30 pm

The US cannabis industry is showing resilience with a projected growth from $30 billion to over $50 billion by 2030. Recent stock pullbacks present investment opportunities, especially with federal legalization efforts gaining momentum. Investors are advised to use technical analysis for informed decisions.

Portfolio Pulse from

November 17, 2024 | 3:45 pm

Cresco Labs Inc. (CRLBF) reported a Q3 loss of $0.02 per share, missing the Zacks Consensus Estimate of a $0.01 loss. This is an improvement from the $0.04 loss per share a year ago.

Portfolio Pulse from

November 09, 2024 | 1:00 am

Cresco Labs Inc. held its Q3 2024 earnings conference call, discussing financial performance and company developments.

Portfolio Pulse from

November 08, 2024 | 3:15 pm

Cresco Labs has reported its third quarter 2024 financial results, highlighting the success of its cash flow-focused strategy.

Portfolio Pulse from

November 08, 2024 | 12:15 pm

Microsoft shares rise as the company reports better-than-expected Q1 2025 GAAP EPS and sales.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 8:05 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.